LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
East-West Biopharma Summit 2025
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Jul 14, 2017
Clinical News
Viking completes enrollment in Phase II hip fracture trial of VK5211
Read More
BioCentury
|
Nov 16, 2015
Clinical News
VK5211: Phase II started
Read More
BioCentury
|
Oct 26, 2015
Clinical News
VK5211: Phase I data
Read More
BioCentury
|
Sep 14, 2015
Clinical News
VK5211: Phase I/II started
Read More
BioCentury
|
Jul 3, 2014
Financial News
Viking files for IPO
Read More
BioCentury
|
May 26, 2014
Company News
Ligand, Viking Therapeutics deal
Read More
BioCentury
|
May 23, 2014
Company News
Ligand licenses five programs to Viking
Read More
BioCentury
|
Jun 17, 2010
Targets & Mechanisms
Hormone attack on AD
Read More
BioCentury
|
Jun 17, 2010
Targets & Mechanisms
Hormone attack on AD
Read More
BioCentury
|
Jun 17, 2010
Targets & Mechanisms
Hormone attack on AD
Read More
Items per page:
10
1 - 10 of 15
